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Abstract
Background: As a consequence of recent RNAseq efforts, miRNAomes of diverse tissues and species are
available. However, most interactions between microRNAs and regulated mRNAs are still to be deciphered. While in
silico analysis of microRNAs results in prediction of hundreds of potential targets, bona-fide interactions have to be
verified e.g. by luciferase reporter assays using fused target sites as well as controls incorporating mutated seed
sequences. The aim of this study was the development of a straightforward approach for sequential mutation of
multiple target sites within a given 3’ UTR.
Methodology/Principal Findings: The established protocol is based on Seed Mutagenesis Assembly PCR (SMAP)
allowing for rapid identification of microRNA target sites. Based on the presented approach, we were able to
determine the transcription factor NKX3.1 as a genuine target of miR-155. The sequential mutagenesis of multiple
microRNA target sites was examined by miR-29a mediated CASP7 regulation, which revealed one of two predicted
target sites as the predominant site of interaction. Since 3’ UTR sequences of non-model organisms are either
lacking in databases or computationally predicted, we developed a Stem-Loop 3’ UTR RACE PCR (SLURP) for
efficient generation of required 3’ UTR sequence data. The stem-loop primer allows for first strand cDNA synthesis
by nested PCR amplification of the 3’ UTR. Besides other applications, the SLURP method was used to gain data on
porcine CASP7 3’UTR evaluating evolutionary conservation of the studied interaction.
Conclusions/Significance: Sequential seed mutation of microRNA targets based on the SMAP approach allows for
rapid structural analysis of several target sites within a given 3’ UTR. The combination of both methods (SMAP and
SLURP) enables targeted analysis of microRNA binding sites in hitherto unknown mRNA 3’ UTRs within a few days.
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Introduction
Over the course of the last two decades the importance of
microRNAs (miRNAs) in regulating crucial biological processes
both in the animal and plant kingdom is recognised. In
particular, the invention and application of next generation
sequencing have led to the discovery of hundreds of miRNAs
in various animals including humans and mice [1-3]. MiRNAs,
which have been identified in numerous taxa, not only regulate
animal ontogeny, but their aberrant expression leads to severe
diseases such as cancer or immune disorders. The next step to
unravelling their role is to elicit how novel and known molecules
function in different cellular contexts. In general, miRNAs
regulate gene expression by affecting protein synthesis either
via translational repression or degradation of mRNA after
deadenylation [4]. Animal miRNAs are expressed as single
transcripts or as clusters in a polycistronic way. After
successive processing by the nucleases Drosha and Dicer, the
active RNA induced silencing complex (RISC) is formed
containing the mature miRNA, which with few exceptions
exhibits imperfect complementarity to the target site in the
mRNA. A general rule for miRNA binding and activity is the
formation of a perfect Watson-Crick hybrid between the miRNA
5’ nucleotides 2-8 (referred to as the “seed” of miRNA) and the
target site of the mRNA generally located in the mRNA 3’ UTR.
Furthermore, advanced miRNA activity is observed for
molecules possessing an adenosine across position 1 and
adenosine or uridine across position 9 [4]. Another rule for
canonical miRNA binding is that bulges or mismatches are
needed in the central region of miRNAs followed by target
complementarity at the 3’ end [5]. However, several studies
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have suggested that non-canonical seed binding also leads to
miRNA mediated silencing [6,7].
Apart from the understanding of miRNA biogenesis and its
regulation, identification of miRNA targets is key to unravelling
mechanisms of miRNA function. However, based on both their
small size and the incomplete miRNA-mRNA interaction, target
prediction and analysis are very demanding and involved. As
reviewed by Alexiou and colleagues [8], the development of
numerous target prediction algorithms e.g. Target Scan [9],
DIANA-microT [10] or RNAhybrid [11] has helped to rapidly
identify putative miRNA targets. For example, Target Scan
prediction is based on the fact that many miRNAs are
conserved among phylogenetically related animals and it
seems highly probable that conserved and aligned seeds in
several species point to a biologically functional miRNA-mRNA
interaction. However, a typical search often results in the
prediction of hundreds of targets. Subsequent RNAhybrid
analysis, an algorithm which finds the energetically most
favourable hybridisation sites of a miRNA in the mRNA 3’ UTR,
is a useful tool for narrowing down the number of potential
targets. On the other hand, while target site prediction for
common model organisms such as humans or mice are in the
majority of cases easy to perform, a lack of 3’ UTR sequence
data of non-model organisms often hampers in silico prediction.
Therefore and prior to prediction of potential target sites, 3’
RACE (Rapid Amplification of cDNA Ends) experiments have
to be performed to determine sequences and follow-up
experiments are required to verify the predicted targets and the
biological functionality of the miRNA. Orom and Lund [12] have
reviewed that the limitation of target prediction using e.g.
mentioned programs relies on few established principles of
miRNA biology not allowing to consider novel aspects of
miRNA target recognition. They conclude that many predicted
targets do not show regulation in validation experiments.
Experimental target identification can be performed using
indicative or straight approaches. Indicative experiments
represent mainly high-throughput methods such as
transcriptome analysis after miRNA overexpression using
either synthetic miRNAs or inhibition by means of
complementary oligonucleotides. These approaches allow
drawing conclusion from the altered expression of affected
genes and pathways and are mainly limited to mRNAs that are
degraded by their targeting miRNAs. Immunoprecipitation of
AGO proteins followed by microarray analysis or sequencing is
a more straightforward approach to identify miRNA targets,
however, involves experimental challenges and difficulties.
Since the final outcome of miRNA action regardless of causing
translational inhibition or mRNA degradation is the regulation of
cellular protein concentration, proteome analysis seems to be
another suitable direct approach giving comprehensive insight
into miRNA target identification [12].
Nevertheless, by either applying an indicative or straight
approach, generated results are mostly validated by means of
luciferase reporter gene assays where mutated seeds serve as
controls. Here we present a convenient strategy to identify
miRNA targets based on a modular approach to sequentially
mutate multiple seeds within a given 3’ UTR. Furthermore, we
present a new Stem-Loop 3' UTR RACE-PCR for rapid
identification of unknown 3’ UTR sequences in non-model
animals. Taken together, presented methods provide a
straightforward strategy for functional and structural analysis of
mRNA-miRNA interactions as examined for several
candidates. The developed approach for miRNA target site
mutagenesis allows for structural analysis of multiple miRNA
target sites of a given mRNA. This innovation is of great
interest, since effective regulation of a particular mRNA
requires multiple target sites of the same or different
microRNAs [5]. The integrative strength of presented
technologies relies on combination of 3’ UTR sequence
identification and functional target analysis in hitherto unknown
data, facilitating discovery of regulative pathways also in non-
model organisms.
Materials and Methods
Cell lines, isolation of total RNA and reverse
transcription
The human cervix carcinoma cell line HeLa (ATCC No.
CCL-2) and human monocytic cell line U937 (DSMZ No. ACC
5) were maintained and passaged twice weekly in RPMI 1640
(Biochrom AG) supplemented with 10% fetal bovine serum
superior (Biochrom AG) and 10 µg/ml Gentamicin (Biochrom
AG). Cultivation of cells was performed in 75 cm2 flasks
(Greiner Bio-One GmbH) at 37 °C and 5% CO2.
Total RNA was isolated using the mirVana miRNA Isolation
Kit (Life Technologies), according to the manufacturer’s
protocol. The RNA quality and quantity of all samples were
assessed as described previously [3]. Reverse transcription of
total RNA was performed as described earlier [13]. Briefly, 1 µg
RNA was treated with 1 U RNase free DNase (Thermo) in 10 µl
total volume according to manufacturer’s protocol.
Subsequently, the treated RNA was reverse transcribed in 20
µl total volume using 0.2 µg random hexamers, 200 µM of each
dNTP and 200 U RevertAid™ Reverse Transcriptase (Thermo)
following the manufacturer’s protocol. Reverse Transcriptase
negative samples served as control for absence of
contaminating DNA.
Statistical Analysis
All experiments were performed considering at least three
biological replicates each measured in triplicates. Unpaired t
tests were performed and two-tailed P values were calculated
using GraphPad Prism version 6.00 for Windows, GraphPad
Software, La Jolla California USA, www.graphpad.com.
Asterisks in figures summarise P values (*: P < 0.05; **: P <
0.01; ***: P < 0.001; ****: P < 0.0001).
Nucleofection and luciferase reporter gene assays
For RNA as well as protein isolation after RNAi, cell lines
were transfected employing the Nucleofector Technology
(Lonza AG) together with 1 x 106 cells and 100 pmol of miRNA
mimics, inhibitors or controls according to the manufacturer’s
instructions. Following interfering molecules were used in this
study: Pre-miR™ miR-155 and 29a Precursors, miRVana
miR-155 inhibitor (Life Technologies), NKX3.1 ON-
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TARGETplus SMARTpool – Human and non targeting siRNA
control (Thermo). Samples for RNA and protein analysis were
taken at 24 and 48 hours after nucleofection, respectively.
For combined detection of Gaussia as well as Cypridina
luciferase activity, nucleofection was performed as described
earlier [14] using 5 x 105 – 1 x 106 HeLa using 0.9 - 1.8 µg
reporter plasmid (pTKGluc derivatives, NEB GmbH), 100 - 200
ng normalisation plasmid (pTKCluc, NEB GmbH) and 100 pmol
synthetic miRNA according to the manufacturer’s instructions.
Luciferase activity was determined using respective Biolux
Assay Kits (NEB GmbH) and white 96 well microplates
(Greiner Bio-One GmbH) together with the automated
luminometer FLUOstar OPTIMA (BMG Labtech).
mRNA degradation assay
Cells were transfected using nonsense synthetic miRNAs,
mimics, inhibitors or siRNAs, respectively. At 24 h as well as 48
h post transfection cells were washed once with ice-cold PBS
and RNA was isolated and reverse transcribed. Target gene
specific RT-qPCR assays were performed as described earlier
[14] using the oligonucleotides given in table 1. mRNA levels
were calculated relative to the nonsense transfected controls.
Protein isolation and Western Blot
Protein was isolated using RIPA Buffer (Cell Signaling
Technology) and according to the manufacturer’s protocol.
Western Blots were performed applying 15 µg of protein
extracts as described earlier [13] using the primary mouse anti-
NKX3.1 (No. ab55781, purchased from Abcam) at 1:500
dilution and the secondary ECL Anti-mouse IgG antibody (No.
NA9310V, purchased from GE Healthcare) at 1:5000 dilution.
GAPDH was detected as a reference protein using the primary
mouse anti-GAPDH (1D4) (No. NB300-221, purchased from
Novus Biologicals) at 1:20.000 dilution and the same
secondary antibody mentioned above at 1:40.000 dilution.
Table 1. Oligonucleotides used in this work.




hSHIP1 SDM f rev gcactgggcttcgattagtcttcacccctccg
hSHIP SDM r fw cggaggggtgaagactaatcgaagcccagtgc
NotIhCASP7-3UTR fw tagcggccgcgctgagaagcaatgggtcac
XhoIhCASP7-3UTR rev ggctcgagaggaattaagcaaccacatttt
hCASP7 SDM2 f rev tcaagaattcaaaagaggtgtttggtgtgaaaacaaagtgcca
hCASP7 SDM2 r fw tggcactttgttttcacaccaaacacctcttttgaattcttga
hCASP7 SDM1 f rev ttcagagaacaaaagaggcgtgtggaaagtttcttccctg
hCASP7 SDM1 r fw cagggaagaaactttccacacgcctcttttgttctctgaa
NotIhNKX3-3UTR fw tagcggccgcctgctaggggctgttgcatt
XbaIhNKX3-3UTR rev gccgtctagacgctgtgttcttcctctgtg
hNKX3 SDM f rev ggatttgggatagctctgattgtatttttaaagg





sscDHH rev i atgcggttctggagagtcac
sscDHH rev ii tcggttcctctatcgtttgg
sscSELPLG rev i gccaccaccaatggagtc
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Oligonucleotides for PCR
All PCR oligonucleotides used in this work were synthesised
by Metabion AG and Sigma Aldrich (table 1).
Seed Mutagenesis Assembly PCR (SMAP)
Templates for mutagenesis of target sites of the gene of
interest were generated using 2 µl of reverse transcribed cDNA
with 10 pmol of each primer (Figure 1; 'geneX 3'UTR fw and
rev'), 1 U Immolase DNA Polymerase (Bioline GmbH), 3 mM
MgCl2, 0.2 mM dNTPs and 10x buffer in 25 µl total volume.
The reaction was started at 95 °C for 8 min, followed by 40
cycles with 45 s at 95 °C, 15 s using a temperature gradient
(59, 60, 61, 62 and 63 °C) and 30 s at 72 °C followed by a
terminal step at 72 °C for 5 min.
Site directed mutagenesis of unique or multiple miRNA target
sites was achieved by applying primers with mutated seed
sequences in PCR reactions providing two (considering a
unique target site) or five (considering two target sites) partly
overlapping amplicons with mutated seeds. Amplicon assembly
resulted in recovery of full length 3’ UTR including the mutated
site. Site directed mutagenesis of each of the flanks was
performed using 0.05-0.1 pmol of gel purified template with 10
pmol of each primer (Figure 1; 'geneX 3'UTR fw' and 'geneX
SDM f rev' for amplicon I or 'geneX 3'UTR rev' and 'geneX
SDM r fw' for amplicon II), 1 U Immolase DNA Polymerase, 3
mM MgCl2, 0.2 mM dNTPs and 10x buffer in 25 µl total
volume. After the initial step at 95 °C for 8 min, the first 10
cycles were run for 20 s at 95 °C, 10 s using a temperature
gradient (54, 55, 56, 57 and 58 °C) and +dT 0.5 °C per cycle
followed by 15 s at 72 °C. The next 30 cycles were conducted
according following scheme: 20 s at 95 °C 10 s using a
temperature gradient (59, 60, 61, 62 and 63 °C) and 15 s at 72
°C followed by a terminal step at 72 °C for 2 min.
Amplicon assembly of unique as well as multiple mutated
sites was performed in a reaction consisting of two successive
rounds. First, equimolar amounts of gel purified amplicons with
overlapping termini were employed for template generation.
Assembly PCR was performed using 0.5 pmol of each
amplicon with 1 U Immolase DNA Polymerase, 3 mM MgCl2,
0.2 mM dNTPs and 10x buffer in 25 µl total volume. The
assembly was started at 95 °C for 8 min, followed by 10 cycles
with 30 s at 95 °C, 15 s using a temperature gradient (59, 60,
61, 62 and 63 °C) and 30 s at 72 °C. The reaction was cooled
down to 4 °C. The amplification of the assembled 3’ UTR
harbouring the mutated target site was achieved by adding 10
pmol of each terminal primer providing the restriction sites (RS)
for cloning (table 1; RS-geneX 3UTRfw, RS geneX-3UTRrev)
with 1 U Immolase DNA Polymerase, 3 mM MgCl2, 0.2 mM
dNTPs and 10x buffer and bringing the total reaction volume to
50 µl. The second round was started at 95 °C for 8 min,
followed by 25 cycles with 30 s at 95 °C, 15 s at 63 °C and 30 s
at 72 °C followed by a terminal step at 72 °C for 2 min.
The mutated 3’ UTR representing the experimental sample
and wild type 3’ UTR serving as a control were digested with
respective enzymes and cloned in pTKGluc (NEB GmbH) as
described earlier [14], resulting in generation of following
plasmids: pTKGhSHIP1; pTKGhSHIP1m; pTKGhCASP7;
pTKGhCASP7m1; pTKGhCASP7m2; pTKGhCASP7m1+2;
pTKGhNKX3; pTKGhNKX3m. Both strands of PCR products
were sequenced to test for accuracy of mutation.
Stem-Loop 3’ UTR RACE PCR (SLURP)
After DNase digestion (as mentioned above) SLURP reverse
transcription of mRNA was performed using 2.5 µM 'SLURP rt'
primer following the protocol described above. The reaction
was started at 42 °C for 1 h followed by an inactivation step at
70 °C for 10 min. PCR amplification was carried out using 2.5
U Immolase DNA Polymerase with additional 2x PolyMate
Additive (Bioline GmbH), 1 µl (500-700 ng) of cDNA pool, 3 mM
MgCl2, 0.4 mM dNTPs, 0.4 µM of each primer and 10x buffer in
25 µl total volume.
The desired 3’ UTR sequence was obtained by means of a
nested PCR protocol using the primer 'fw i' binding at the 5’
end of the cDNA provided by the 'SLURP rt' primer and a first
gene specific primer (GSP) at the 3’ end of the 3’ UTR (GSP
rev i). A second round of the nested PCR was performed to
enhance specificity and product yield using inlying primers 'fw
ii' that bind additional sites within the introduced 'SLURP rt' and
'GSP rev ii'. Both reactions of nested PCR started with initial
denaturing at 95 °C for 10 min and only employed 'GSP rev i'
or 'GSP rev ii', respectively. Linear amplification was conducted
by running 10 initial cycles consisting of denaturing for 30 sec
at 95 °C, annealing for 30 sec at 58-62 °C, and elongating for
1-2.5 min at 72 °C. Subsequently, either 'fw i' or 'fw ii' were
added to the reaction and 30 cycles of denaturing, annealing
and elongation were performed according to the first 10 cycles.
The second round of the nested PCR was performed using
0.5-1 µl of the first reaction as a template. Both strands of PCR
products were sequenced using GSP primers directly or primer
walking after cloning.
Results and Discussion
Analysis of miRNA-target interaction by Seed
Mutagenesis Assembly PCR (SMAP)
DNA manipulation by site directed mutagenesis and
assembly via overlapping PCR termini is a well established
approach [15] for altering the genetic code or analysing cis
regulatory elements by fragment substitution or insertion.
Although miRNA interaction with respective target mRNAs
relies on incomplete complementarity, Watson-Crick pairing of
the nucleotides 2-8 (seed) is regarded to be essential for
miRNA mediated silencing [16]. Consequently, mutagenesis of
the seed sequence within a predicted miRNA target site is a
commonly accepted strategy to evaluate bona-fide miRNA-
target interaction. Therefore, we have established a protocol for
mutagenesis of seed sequences based on site directed
mutagenesis and assembly of mutated termini. Since several
target sites of a particular or multiple miRNAs may occur within
the 3’ UTR the approach is fully applicable to perform
sequential mutagenesis of multiple target sites allowing for
structural analysis. For evaluation of the presented approach,
we first considered the known interaction between SHIP1 and
miR-155 [17]. After template generation using specific primers
for the SHIP1 3’ UTR (Figure 1 A) the extended seed sequence
was mutated by performing two individual PCR reactions
Structural Seed Analysis
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Figure 1.  Concept of Seed Mutagenesis Assembly PCR (SMAP).  Figure shows seed mutagenesis of miR-155 targets SHIP1
and NKX3.1. Gel images show amplicons obtained after each step applying a gradient PCR, while NC represents the no template
control at the lowest annealing temperature. Section A: 3’ UTR amplicons were generated harbouring the predicted target site.
Section B: Oligonucleotides were used for seed mutagenesis and generation of overlapping termini that possessed approximately
12 nucleotides at the 3’ as well as 5’ ends flanking the mutated site. Section C: Assembly PCR of amplicons with mutated termini
provided 3’ UTRs including the mutated seed. The amplicon was fused to a luciferase gene for reporter gene assays. Relative
luciferase activity (Luc Gaussia : Luc Cypridina) was determined using a miR-155 mimic compared with a nonsense miRNA control
together with the mutated seed (pTKGhSHIP1m) as well as wild type control (pTKGhSHIP1) . The columns show means of
normalised luciferase activity of three biological replicates each measured in triplicates while error bars show the standard deviation.
Asterisks indicate statistical significance between samples (****: P < 0.001, unpaired t test).
doi: 10.1371/journal.pone.0081427.g001
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enabling site directed mutagenesis. The seed location was
chosen to generate overlapping amplicon termini in each
reaction (Figure 1 B) by means of oligonucleotides including
mutated seed sequences. For this purpose, two
complementary oligonucleotides were employed in each PCR
possessing about 12 nucleotides at the 3’ as well as 5’ end that
flanked the mutated seed region. This design turned out to
optimally stabilise the mutating primers in the PCR providing
efficient seed mutagenesis and was applied as a general
principle. We also developed a PCR protocol promoting
specific and efficient mutagenesis (see amplicon I and II in
Figure 1 B). The reaction was composed of two successive
basic conditions. Initial 10 cycles were run applying decreased
annealing temperatures (54-58 °C gradient +dT 0.5 °C per
cycle), which allowed for proper binding of the mutating
oligonucleotides (Figure 1 B, geneX-SDMr fw or -f rev) and
generation of first products harbouring the terminus with altered
seed sequence. The annealing temperature was increased for
the following 30 cycles (59-63 °C gradient), guaranteeing
targeted amplification of the specific product. As shown by the
gel images in Figure 1 B, the protocol generated mutated
products with nearly complete absence of by-products. The
assembly of mutated and overlapping ends was performed by
employing a PCR protocol composed of two successive steps.
Within the first step (10 cycles), both amplicons were
assembled using low concentrations of each product (0.5
pmol). The second step was succeeded by adding terminal
primers flanking the full amplicon (Figure 1 C) and providing 5’
overhangs introducing restriction sites for cloning in the
luciferase reporter vector pTKGluc. Resulting plasmids
harboured either the mutated (pTKGhSHIP1m) or the wild type
(pTKGhSHIP1) SHIP1 3’ UTR and were fused with the 3’ end
of the Gaussia reporter gene as well as co-transfected into
HeLa cells with miR-155 mimics or non-targeting controls to
evaluate interaction. As shown in Figure 1 C, miR-155 caused
approximately 30% down-regulation of luciferase activity when
fused to the wild type SHIP1 3’UTR and compared with the
nonsense transfected control. Seed mutagenesis resulted in no
difference in luciferase activity after miR-155 as well as
nonsense control transfection verifying not only the miR-155-
SHIP1 interaction but also validating the proposed protocol.
NKX3.1 Is a miR-155 Target
In vivo and in vitro overexpression of miR-155 represses
SHIP1 in hematopoietic cells, resulting in increased activation
of AKT/PKB after LPS stimulation [17]. SHIP1 is a repressor of
PI3K mediated AKT/PKB activation via hydrolysis of the
second messenger phosphatidylinositol P3 (PIP3). It
inactivates PI(3–5)P3 by hydrolysis to PI(4,5)P2 [18]. Another
PI3K antagonist is PTEN, which has a similar effect on
AKT/PKB inhibition via its 5’ phosphatase activity [19]. Loss of
PTEN in a prostate cancer model was shown to be based on
loss of the homeobox-containing transcription factor NKX3.1,
resulting in AKT/PKB activation [20]. Since NKX3.1 is also
expressed in monocytic cells (Figure 2 B and C) we speculated
that apart from SHIP1 it may play a PTEN dependent role on
AKT/PKB signalling. Interestingly, in search of further potential
miR-155 targets that may regulate AKT/PKB signalling, our in
silico analyses predicted NKX3.1 to be a potential target of
miR-155. We identified one miR-155 target site within its 3’
UTR possessing an extended seed sequence with an
adenosine across position 1 and a uridine across position 9
(Figure 1 A), which according to the studies of Fabian et al.
indicates enhanced interaction and activity [4]. NKX3.1 is
expressed during embryonic development but also in adult
prostate tissue; its loss is related to prostate cancer [21,22].
More recently, it was shown that NKX3.1 mediates proliferation
of TAL1 expressing human T cells in acute lymphoblastic
leukemia [23].
Following the SMAP protocol, we mutated the seed
sequence of the identified NKX3.1 target site and fused it to the
Gaussia luciferase, resulting in the generation of the plasmid
pTKGhNKX3.1m and the wild type control (pTKGhNKX3.1).
Co-transfection of miR-155 with the wild type 3’ UTR
(pTKGhNKX3.1) resulted in 45% mean down-regulation of
luciferase activity in HeLa cells compared with the nonsense
transfected controls. However, extended seed mutagenesis
(pTKGhNKX3.1m) resulted in no difference in luciferase activity
after miR-155 as well as nonsense control transfection (Figure
2 A). The potent down-regulation of luciferase activity pointed
out NKX3.1 to be a mir-155 target. For validation of luciferase
reporter assay data, we employed the human moncytic cell line
U937 to examine miR-155 interaction with intrinsic NKX3.1
performing RNAi experiments. For this purpose, U937 were
transfected with miR-155 mimics while NKX3.1 siRNA as well
as nonsense miRNAs were considered as controls. miRNA-
target interaction results in silencing based on translational
inhibition or mRNA degradation after deadenylation [24]. We
first performed mRNA degradation assays after RNAi (by
means of RT-qPCR) to find out if cellular NKX3.1 mRNA levels
are affected by miR-155 transfection. As shown in Figure 2 B,
miR-155 transfection resulted in stable NKX3.1 transcript levels
at 24 h post transfection compared with nonsense controls,
while mRNA levels decreased to 67% after NKX3.1 specific
siRNA transfection compared with nonsense transfected
control. After 48 h the mRNA levels were decreased to 81%
after miR-155 or 80% after siRNA transfection, respectively
(Figure 2 B). To assess the effect of miR-155 on NKX3.1
translational repression, 48 h post transfection cells were lysed
accordingly and subjected to Western Blots. As shown in
Figure 2 C, miR-155 mimic caused clear reduction of cellular
NKX3.1 protein levels compared with the nonsense control
while limited knock-down was achieved applying the NKX3.1
specific siRNA. The application of a miR-155 antagonist tended
to raise NKX3.1 levels but not significantly (data not shown).
Relative quantification of three independent Western Blot
experiments resulted in averaged 40% decreased NKX3.1
protein levels compared with nonsense transfected controls
(Figure 2 C). Since the SMAP protocol is proposed to evaluate
physiological targets of miRNAs we wanted to exclude that the
observed down-regulation of luciferase activity resulted from
elevated concentrations of miRNA due to transfection.
Therefore, endogenous miR-155 levels were considered for
down-regulation of luciferase activity. Since it is known that
LPS induces miR-155 expression in hematopoietic cells [25],
U937 were stimulated with LPS and transfected with respective
Structural Seed Analysis
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Figure 2.  SMAP reveals the transcription factor NKX3.1 as a miR-155 target.  Section A: Luciferase reporter assays after
mutagenesis proved NKX3.1 as a miR-155 target. Relative luciferase activity (Luc Gaussia : Luc Cypridina) was determined using a
miR-155 mimic compared with a nonsense miRNA control together with the mutated seed (pTKGhNKX3.1m) as well as wild type
control (pTKGhNKX3.1) . The columns show means of normalised luciferase activity of three biological replicates each measured in
triplicates while error bars show the standard deviation. Asterisks indicate statistical significance between samples (****: P < 0.001,
unpaired t test). Section B: mRNA degradation assays by means of RT-qPCR experiments are shown detecting relative NKX3.1
levels (reference gene: GAPDH). U937 were transfected with miR-155, nonsense miRNA and NKX3.1 siRNA. RNA was isolated at
24 and 48 h post transfection. Columns show mean relative NKX3.1 transcript levels (± SD) of three biological replicates each
measured in triplicates compared with nonsense transfected controls. Section C: Western Blots detecting NKX3.1 and GAPDH
(reference protein) are shown using the monocytic U937 cells transfected with miR-155, nonsense miRNA and NKX3.1 siRNA.
Intrinsic NKX3.1 levels are decreased after miR-155 transfection compared with nonsense controls and siRNA (48 h post
transfection). The bar graph shows the luminescence-based relative quantification of protein (NKX3.1:GAPDH) of three individual
biological replicates while error bars show the standard deviation. Asterisks indicate statistical significance between samples (*: P <
0.05, unpaired t test). Transfection efficiency was evaluated by transfecting Cy3 labelled nonsense siRNA and fluorescence
microscopy. While NKX3.1 translation is markedly inhibited by miR-155, cellular NKX3.1 mRNA levels remained stable after
miR-155 at 24 h and decreased after 48 h suggesting slow cellular turnover rates of miR-155 directed NKX3.1 inhibition. Section D:
Endogenous miR-155 expression leads to decreased luciferase activity of transfected reporters. The bar graph on the left hand side
shows relative miR-155 expression in U937 cells at 5 and 24 h after LPS stimulation. The other bar graph shows that endogenous
miR-155 expression results in clear repression of luciferase activity (nonsense transfected) while ectopically introduced miR-155
results in elevated repression and mutated controls remain unaffected. The columns show means of three biological replicates each
measured in triplicates while error bars show the standard deviation. Asterisks indicate statistical significance between samples (**:
P < 0.01,***: P < 0.001, unpaired t test).
doi: 10.1371/journal.pone.0081427.g002
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reporter plasmids (pTKGhNKX3.1 and pTKGhNKX3.1m) and
nonsense miRNA as well as miR-155. This experiment clearly
showed that in nonsense transfected controls endogenous
miR-155 expression supressed the luciferase activity markedly;
while miR-155 transfection had synergistic effects compared
with SMAP based mutated controls (Figure 2 D). This approach
is in accordance with the studies of Wang et al. [26] who
suggested that induction of endogenous miRNAs has possible
advantage of more accurately representing genuine miRNA-
directed repression. Consequently, our experiments turned out
NKX3.1 to be a genuine miR-155 target because reporter
assays showed decreased luciferase activity after miR-155-
NKX3.1 interaction as well as intrinsic NKX3.1 protein levels
were decreased after miR-155 transfection. As a result, we
conclude that miR-155 mediated silencing of NKX3.1 in U937
cells seems to predominantly rely on translational inhibition
closely linked to a delayed mRNA degradation. This suggests
that miR-155 causes moderate cellular mRNA turnover rates of
NKX3.1 in monocytic cells when compared with the specific
siRNA, which showed a clear degradation right after 24 h. As
mentioned above, miR-155 functions as an AKT/PKB activator
in hematopoietic cells by down-regulation of the phosphatase
SHIP1. Moreover, the loss of another negative regulator of
AKT/PKB signalling, the phosphatase PTEN, is based on
lacking NKX3.1. Silencing of SHIP1, on one hand, as well as
NKX3.1 downregulation leading to PTEN inhibition, on the
other hand, suggest synergistic effects resulting in potent
activation of AKT/PKB signalling by miR-155 in monocytic cells.
Our on-going studies will decipher the role of NKX3.1 in
mentioned signalling pathways.
Sequential seed mutagenesis by SMAP revealed one of
two predicted target sites to confer predominant
interaction of miR-29a and its target CASP7
For determination of new miRNA-mRNA interactions we
apply a strategy based on employing a series of target
prediction and pathway analysis tools for computational
identification of most probable targets. This protocol relies on
initial target prediction of selected miRNAs of interest using the
tool Target Scan [9]. The generated list of hypothetical targets
is used as a gene list to enter a bioinformatics database such
as DAVID [27] and trace potentially affected pathways. DAVID
has the benefit of combining several pathway databases such
as KEGG or Biocarta. Dependent on the chosen pathway
database, this step allows for selection of pathway
accumulated targets of interest (e.g. after treatment, disease
etc.) because targeting of multiple components of a signalling
pathway by a given miRNA would indicate robustness of
predication. The miRNA-mRNA interaction between identified
targets is evaluated using the tool RNAhybrid, which tests for
hybridisation characteristics between a given miRNA and its
target mRNA [11]. The presented workflow allows data filtering
and narrowing down of the number of predicted targets
concentrating on most probable interactions.
Based on integrative analysis of miRNA and mRNA
transcriptomes after mycobacterial infections and following the
workflow described above, we were able to define CASP7 as a
miR-29a target [14]. In this previous study, we predicted two
potential target sites within the CASP7 3’ UTR (Figure 3),
however no further structural analysis of target site impact on
miR-29a mediated CASP7 regulation has been performed.
Based on the established SMAP protocol, we sequentially
mutated each target site in the present study to evaluate target
site impact on miR-29a mediated CASP7 regulation. For
individual but also combined target site mutagenesis, the
CASP7 3’ UTR was theoretically divided in three segments
defined by location of predicted target sites as well as 5’ and 3’
termini of the 3’ UTR. The locations of each seed were taken
as binding sites for mutagenesis primers providing overlapping
termini as described above (Figure 3 A). As shown in Figure 3
B, this design allowed the generation of 5 amplicons either
mutating target site #1 (in amplicons I and III) or target site #2
(in amplicons II and V) or both target sites (in amplicon IV). Full
length 3’ UTRs with individually mutated seed sequences were
obtained after assembly of amplicons I and III (Figure 3 C) or II
and V (Figure 3 D), respectively. On the other hand, the
assembly of amplicons I, IV and V in one reaction resulted in a
full length 3’ UTR containing both mutated seeds (Figure 3 E).
As shown in Figure 3 F, the developed PCR regime resulted
again in amplification of specific bands both for mutagenesis
and assembly. Each of the three assembled amplicons as well
as the wild type 3’ UTR were fused to the Gaussia luciferase as
described above providing the following reporter plasmids for
structural analysis of target sites: pTKGhCASP7 (control),
pTKGhCASP7m1 (mutated seed 1), pTKGhCASP7m2
(mutated seed 2) and pTKGhCASP7m1+2 (mutated seeds 1
and 2).
Successive luciferase reporter assays using the wild type 3’
UTR (pTKGhCASP7) showed more than 50% down-regulation
of luciferase activity when co-transfected with miR-29a
compared with nonsense controls (Figure 3 F). Interestingly,
this modular approach showed that mutagenesis of target site
#1 resulted in less than 20% mean down-regulation of
luciferase activity. On the other hand, alteration of the seed
sequence within target site #2 produced an approximate 40%
decrease of luciferase activity while there was no difference
between miR-29a and nonsense transfected controls when
target sites were mutually mutated (Figure 3 F). This
experiment revealed target site #1 to be the main cis regulatory
element for miR-29a mediated CASP7 regulation. This is
supported by the fact that Target Scan analysis of miR-29a-
CASP7 interaction showed only conservation of target site #1
among mammals but not target site #2. On one hand, target
site #1 mutagenesis did not restore the nonsense control
condition and alteration of the seed sequence within target site
#2 did not result in full magnitude of down-regulation. On the
other hand, mutual mutagenesis resulted in no effect between
miR-29a and nonsense transfection. As a result, we conclude
that synergistic effects of both sites exist. This is interesting,
since target site #2 is a non-canonical miRNA target site with
one G:U wobble within the seed sequence and without central
stretches of non-complementary regions possessing 90%
complementarity to miR-29a. Because it features only a single
mismatch across the position 12 (not possessing a central
bulge) of miR-29a (Figure 3 A) we mutated the extended seed
sequence between nucleotide 1 and 11. Interestingly, studies
Structural Seed Analysis
PLOS ONE | www.plosone.org 8 November 2013 | Volume 8 | Issue 11 | e81427
Figure 3.  Sequential mutagenesis of multiple miR-29a target sites within the 3’ UTR of CASP7 by means of SMAP.  Section
A: Full length 3’ UTR of CASP7 was generated harbouring both identified target sites of miR-29a. Section B: For individual but also
combined target site mutagenesis, the 3’ UTR was theoretically divided in three segments defined by locations of target sites.
Sections C-E: Modular assembly of amplicons resulted in sequential mutagenesis of target sites. Section F: Gel image shows five
amplicons after mutagenesis as well as assembled products for reporter gene fusion. NC represents the no template control of the
assembly PCR. Relative luciferase activity (Luc Gaussia : Luc Cypridina) was determined using a miR-29a mimic compared with a
nonsense miRNA control together with the mutated target site 1 (pTKGhCASP7m1), mutated target site 2 (pTKGhCASP7m2),
mutated target sites 1 and 2 (pTKGhCASP7m1+2) as well as the wild type control (pTKGhCASP7) . The columns show means of
normalised luciferase activity of three biological replicates each measured in triplicates while error bars show the standard deviation.
Asterisks indicate statistical significance between samples (*: P < 0.05; ***: P < 0.001, paired t test).
doi: 10.1371/journal.pone.0081427.g003
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e.g. of Caenorhabditis elegans have shown that perfect
Watson-Crick pairing along the seed is not a fundamental
condition for miRNA mediated silencing [7]. Also more recently
it was shown that G-bulge sites at positions 5 or 6 of seeds are
bound by miR-124 in the mouse brain and confer efficient
silencing [6]. The identified target site #2 within the CASP7 3’
UTR is conserved between human and Chimpanzee but not
Rhesus, which suggests novel evolutionary acquisition in
higher primates that potentially confers effective CASP7
repression through synergistic effects in Hominidae. This
hypothesis is based on the knowledge that multiple sites within
the same 3’ UTR for the same or different miRNAs are needed
for enhanced inhibitory activity [5]. Apart from these findings,
our study on the CASP7-miR-29a interaction convincingly
showed that observed effects on luciferase activity result from
number and nature of sites rather than elevated concentrations
of miRNA and putative target sequences due to transfection.
Taken together, it points out the SMAP protocol as a tool for
identification and validation of physiological targets of miRNAs.
Rapid identification of 3’ UTR sequences by means of
Stem-Loop 3’ UTR RACE PCR (SLURP)
In recent years we have focused our studies on miRNA
regulation of post natal intestinal development and disease
using piglets as a model [3,28]. In contrast to humans or mice,
in non-model organisms such as pigs sequence data on
untranslated mRNA regions are either entirely or partly lacking.
Since these sequences are needed for prediction of miRNA-
mRNA interactions, we were confronted with the problem of
generating de novo 3’ UTR sequences by means of RACE
experiments. For straightforward and eased investigation of 3’
UTR sequences, we developed a new RACE protocol called
SLURP that is based on employing a stem-loop oligo (dT)
primer for cDNA generation. This anchored oligonucleotide
consists of a 3’ oligo (dT)20 fragment hybridising with the first
adenosines of a polyadenylated RNA molecule followed by a 5’
part, which provides two primer binding sites for a nested PCR
hidden in a stem-loop secondary structure. The secondary
structure is stabilised by a stem region composed of 14
complementary nucleotides having a calculated TM=47 °C and
a dG=-22.6 kc/m. This avoids double-strand dissociation during
cDNA synthesis. The use of an anchored stem-loop
oligonucleotide harbouring primer binding sites for subsequent
nested PCR avoids mispriming since binding sites are blocked
during first strand synthesis by means of stem-loop formation
(Figure 4 A). Increased temperature during PCR unfolds the
secondary structure making the binding sites accessible. The
use of two batched gene specific reverse primers (GSP rev i
and ii, Figure 4 B) together with two forward primers binding to
the region provided by the stem-loop primer, allowed a nested
PCR approach for enhanced specificity and product yield
(Figure 4 B). A PCR protocol based on linear amplification over
the initial 10 cycles followed by 30 cycles of exponential
amplification turned out to result in enhanced specificity of the
approach. For this purpose, the first 10 cycles were performed
by only adding the GSP rev i (or for the 2nd round of the nested
PCR GSP rev ii) followed by addition of the fw i primer (or for
the fw ii for the 2nd round of the nested PCR) for the remaining
30 cycles. In this study, SLURP was used to identify the
sequences of four porcine 3’ UTRs that were chosen according
to our research foci. Based on partially known mRNA
sequences, we determined full length 3’ UTR of DHH (445 bp,
Accession No. HE651025), SELPLG (768 bp, Accession No.
HE651024), TGFBR3 (1378 bp, Accession No. HF566399) and
CASP7 (570 bp, Accession No. HF566398).
As mentioned above, we have already shown that CASP7 is
regulated by miR-29a in primary human macrophages [14]. In
another study using pigs as a model, we determined that
miR-29a mediated CAV2 regulation leads to increased cellular
levels of active CDC42 [28]. Interestingly, it is known that
CDC42 is cleaved by CASP7 and CASP3, but not by other
caspases such as 6 and 8 [29]. As a result, we became
interested in examining similarities between human and
porcine binding sites within the CASP7 3’ UTR, although the
analysis of CASP7 binding site #2 for miR-29a revealed no
conservation among primates. Since relating porcine sequence
data relied either on computational predictions
(XM_001928978) or partial mRNA data (AK233348) we
decided to re-sequence the porcine CASP7 3’ UTR employing
the SLURP protocol. Porcine target site #1 was highly
conserved compared with the respective human binding site
possessing 89% sequence identity (Figure 4 C) and complete
seed complementarity. However, porcine target site #2 (Figure
4 C) showed only 76% identity between pigs and humans and
exhibited one mismatch across the 3rd nucleotide of miR-29a.
Although CASP7 target site #2 is a non-canonical binding site
characterised by the mismatched nucleotide in the seed region,
it is known that such sites can still confer inhibition and that
potent silencing of target mRNAs by miRNAs relies not only on
target site nature, but also on the number and accessibility of
binding sites [5]. Consequently, 3’ UTR secondary structures
affect inhibition properties by determining the accessibility of
target sites [30]. Our studies suggest that sole fusion of the
target site (for example realised by hybridised oligonucleotides)
to a reporter gene only partially resembles the inhibition
mechanisms since secondary structure formation of 3’ UTRs
are not considered. Therefore, we suggest employing long 3’
UTR fragments for reporter gene fusions including mutated
controls (generated by SMAP) to mimic molecular interactions
as it considers cis regulatory elements as well as site
accessibility. The structural analysis of miRNA-mRNA interplay
in hitherto unknown mRNA sequences as presented here
allows for examining the interaction capability of a given site by
means of seed mutagenesis. In addition, sequential seed
mutagenesis enables distinction between the activities of
multiple binding sites within the same 3’ UTR. At the same
time, binding site accessibility is resembled based on
secondary structure formation of 3’ UTR since long fragments
including mutated seeds are compared with wild type 3’ UTRs.
Conclusions
Interaction between microRNAs and mRNAs has shed light
on the regulation of many cellular pathways in development
and disease. Functional analysis of predicted interactions
employing straightforward protocols as presented here is a
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Figure 4.  Rapid identification of 3’ UTR sequences by means of Stem-Loop 3’ UTR RACE PCR (SLURP).  Section A: Figure
shows stem-loop primer (SLURP rt) binding and priming of the reverse transcription reaction. As highlighted in green and yellow, the
'SLURP rt' provides two primer binding sites for a nested PCR that are hidden by the secondary structure. Section B: The use of two
batched gene specific primers (GSP rev i and GSP rev ii) together with 'fw i and fw ii' binding to the sites provided by the 'SLURP rt'
allowed for a nested PCR. Section C: Identified miR-29a target sites within the 3’ UTR of porcine CASP7. SLURP based sequence
revealed that target site 1 was highly conserved between humans and pigs. The predicted target site 2 suggested non-canonical
binding of miR-29a as also shown in humans.
doi: 10.1371/journal.pone.0081427.g004
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fundamental step to decipher mechanisms. The developed
approach for microRNA target site mutagenesis based on
nucleic acids synthesis strategies, allows for structural analysis
of multiple microRNA target sites of a given mRNA. This
innovation is of great interest, since effective regulation of a
particular mRNA requires multiple target sites of the same or
different microRNAs. The integrative strength of presented
technologies relies on combination of 3’ UTR sequence
identification and functional target analysis in hitherto unknown
data, facilitating discovery of regulative pathways also in non-
model organisms.
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